However, the assessment of LPS in serum or plasma has significant challenges [31,32], including its short half-life, and to overcome these limitations, the determination of LBP (a proxy for LPS) is considered to be a better biomarker for endotoxemia [33]. This evidence concerns the gene LBP and serum lipopolysaccharide activity.